{"name":"Cipla USA Inc.","slug":"cipla-usa-inc","ticker":"","exchange":"","domain":"ciplausa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNNzVsaHZ5S3ppNGpORlFEeWZhWldjUzBnaHU2bklvMUs2VE9mc1NZUV9wUnIyWnNqc1pLbTBhT0RnZl92a2dFQ2tOVDdKaHJzLWlYU3c2dUk4eWpYQkpmMGtZemFiV1g3clZpMTBGVm5BUHJTbHNBdlJIRmEyMWFadnNYRUlUWXA2M1p0d28yR2xrWTVLWG90bDI5Slo4MEhBVXpIWjEyeHBkc21NZjJ3MmJ3MWxZa1YyZ0NiU0FpM2hOc3pVendKWEFUenJjQzdQQ18w0gHaAUFVX3lxTE8xMjBlZ1RmNWRhbVh3dVBLb0YxN3psQ2wyRUNKZGVFSThDM0NoVjVOR1BITUVBUV9hUE5Jd3lqTUxucmlPdXNDMkxlcXJZQ0stMVlmeGhvUUdXUTBVbHVSVGFGS19YNmNxa1VOcnZjSHJDNDNPd1hFa2Ffb3RndWRYeWNZYnNzaEN3NmlHSElQdGdKYnRzb0JVZkthbFRIcXRTSGFRaC0tRGx1OWxPTXJBWUlaLUI4V0tqWEgwcU5UUkx4Q25JYmdsSEIwWHV6WVBkVm96dFRFMWhB?oc=5","date":"2026-04-04","type":"regulatory","source":"Indian Pharma Post","summary":"Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib - Indian Pharma Post","headline":"Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE9rUkptVUZkc3ladzNNZUpJNVh1dFBSRThSX0hyaGVoQWNwUDBfZVRHRmZMUUxTYm5yQmVyLWtCdGhMSXpPdGx6emZ4eWo4cTdEOERMaTF1UXVXdw?oc=5","date":"2026-04-03","type":"regulatory","source":"Lelezard","summary":"Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis - Lelezard","headline":"Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary F","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOMGNwd2FJdkRrNzBncW5PSFE4SkFNdXlhNFN1V0V3VEN6QUFNX3RZdE9fN3d0akRWNFJncGotSUtKWmFuX1VVb3lrRnlxRVU2aDF3WmhIT011SGJ2NmR2ME9jamZFRXc2TXFzd1luZ3RhNU9wZWc1S0w1QXktQUNSVHpnNUI0OUpsVU85cC15WEMydm1RaGNwaERlSzhOYm1vTFpObnJIYw?oc=5","date":"2026-03-21","type":"pipeline","source":"INDIA New England News","summary":"Cipla’s U.S. Unit Recalls More Than 400 Cartons of Anti-Cancer Drug Nilotinib - INDIA New England News","headline":"Cipla’s U.S. Unit Recalls More Than 400 Cartons of Anti-Cancer Drug Nilotinib","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-16","type":"patent","source":"The Manila Times","summary":"Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation - The Manila Times","headline":"Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-11","type":"pipeline","source":"medicaldialogues.in","summary":"Cipla to Recall Lanreotide Injection in US, Temporary Supply Disruption Expected - medicaldialogues.in","headline":"Cipla to Recall Lanreotide Injection in US, Temporary Supply Disruption Expected","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNcVdDb016b0xkdmtleERyY2JrX25ONzRtV2NXVEFYR2doTko3aWs3MC1kdzI3ZjFzVkJtMnZxdFpWR0lfVER1VFlxRWFSRDZyZWdJZ2ljYk01V1R1Vk9CSGNoYk5Vb3FabklMU3h1bGRhREFfbWh3WUtidnBhRTFsT19tZjJBOS00ZTRiZVZsZnJCZWRkaTViMVNMaHdYS1hWSi1vYU9iSlNFQnp3MHkteFFUTWtYSFZsX29IajlvZ2xfYjFGZTM2MUNNdVljM3Z2ZDA1ZHRkYl9ZOE1UNFpV?oc=5","date":"2026-03-09","type":"pipeline","source":"scanx.trade","summary":"Cipla USA Starts Recall of Lanreotide Injection Batches, Leading to Short-Term Supply Issues - scanx.trade","headline":"Cipla USA Starts Recall of Lanreotide Injection Batches, Leading to Short-Term Supply Issues","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-08","type":"regulatory","source":"The Hindu","summary":"Cipla recalls over 400 cartons of cancer drug in U.S.: USFDA - The Hindu","headline":"Cipla recalls over 400 cartons of cancer drug in U.S.: USFDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNTXNLaE9KMzA0NUt3d1dBRk9ZSjBKQmpsMU9idENCdFVyQkZWM2d2bUcyMkxYSHBtTl9XWE92bVM5Q3ZwcHA4eE52Yzc1X2pSeXdGMllBMk9KTzZNYy1qenVCUEk3UzFoTkJpZGRCYTk2bmRyRFRsQnF0SG1ZV3dCb21Ecm02TkxnZWszOHUtSlV6TXh6WHVESGo1Rk9yazVXWk5WT0xXZk5ac2RwN2VRMF9rakd4UkhTa2FpTHNjRHZDMmc3dmNZcFFHVW5Gem5zT19GNXVMVVRaTVFGMmd4UTRTVlBxRFRkci1wX0d3WnlwRzc0cXdad0NLY0o4RExaZV84?oc=5","date":"2026-02-27","type":"patent","source":"PR Newswire","summary":"Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy - PR Newswire","headline":"Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPYTc0RDBiRzhLSy01cTNaVW9oSERFM1pXLThkcmNkbHV1NHVWcVd3SFk4Sk5sbmlEREVvdGdpVUlpQ0tCU3gza2wtVUFZSFZ1aXhBWlhmcXdWb2dXYTZCdkZNMnlVTjVxdmd2cFBwOUhEMENXVmZwcXBvTzdfYl9FNF9vbnpEaHkwRWFxLVVqWkRWMXRVUzNwNnZPa0EwX3pCZTB1cUtsSEIzSDBYZDdVSHhMN0tSMXoxd3JLRGhiNXh2Z3ZWeG9uV3VyWDFSLXVYY3lsU0Z4TV8?oc=5","date":"2026-02-10","type":"regulatory","source":"Whalesbook","summary":"Cipla's US Subsidiary Gets 2 Observations in FDA Inspection - Whalesbook","headline":"Cipla's US Subsidiary Gets 2 Observations in FDA Inspection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOajljVWtaLW1DZUIzRy1vSlhPYU9YT3AtbmFlLXBJb1JmRDBEM0Y3RVRUVUswVnJveFdEX29MVFV5Tkp5bVh6NTdZV3N0aVBHMklPM2U0Qk5tUUdLLTZvaHpfek1EV0NZcDg4ZFlCLU5meGE4YThHMkVuZmNjSTh6clNtbVV5VGcwblE3VEVTMndLbnNqY1JhOVN0ZlVDUU1fcGFDeUVhcHduQXJWMTdSb2RmSk5CVnpEVmJmWjBWb3RMZS1vRkQ5UElqWWNYZEw0S01wUFdKekg2dzVsSUl1a043Yk1HM3ZEZmZkNkY5Tmpna3lPc2RUczNYVXfSAYICQVVfeXFMUGw2cHhnOC1fNHZ0aWE2RV8tZmMzLWxXcUIza1hfa2c0ajZvQmpMWE1HSGFESkg4dXFZaXB6aUJuN3d3dzRUN2JiNFZyY3F0N1RvdE1WVW1nQ1EzeHljcUM2eWFZbFdEOUlDek5CdWVIQWVDMzllVm9RX1BNMkpfWE92anhNaW10S0xsdEpGRGJqRFZxRWNGanpaeU00bFBNTVZGazFraTdmdU1teXpGb3pWX1VHYkgyWkdEWHJYZFRPVGhkRDJtWU8wVFBIemhDTENleFUtOWUtdGVGQUdaRnJMYm9yaC02OEhiR1JlQ0l3bGlQNzNHdVRpcGJRWUFEZ0p3?oc=5","date":"2026-01-26","type":"regulatory","source":"The Economic Times","summary":"Sun Pharma, Cipla recall products in US over manufacturing issues: USFDA - The Economic Times","headline":"Sun Pharma, Cipla recall products in US over manufacturing issues: USFDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQeEJ4cFFXLVBqTmlKQl9rNm9qRU93Y3NRZGx0bnB4djh1LVlvSVlSWk1MU3BYNzFubEVrUllYVm9fb2pRaGFiaHpVdERtSUxhUWFNdXdwS0hMRmloYTJTUXJFeGtPOGdqRFZqV2dfU0xUV1pYclZSWHY2LUV2Qk5QUDM0eHFHZElOYnY4T2pLSm12NzRST3FlczMycFdkVGVnMTJYSNIBrAFBVV95cUxQZDQ3NWlLQWNFX3kzOUJzcDd3VHFlVXVlWUVTM29SN3pEZ3UzODJ1b0ltU3BNTTJ5SldmbjF6SGRDLVdwZTkyOHdLeWllczhnQUNhVWpQeGk2SkpKSk5JcWh0RHpSV0R2d1V2emRGVG1CVGI0QnRGLTVMRzk2YzAwX2xqUkVLN05Odmp0VXVlNTRDN3ZENW5sQUhYeWhDU1ByUW9JOWlUdnU0VUpi?oc=5","date":"2026-01-26","type":"pipeline","source":"NDTV","summary":"Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues - NDTV","headline":"Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNZTNyMWVReUtIaGZBd0t6anNBakNuaEZBRnhvU0g1X2E2RE9YUFZWZUFvXzdFUTk3UUN3UTlOcWVRMmxwNkxOVU1SbmRGR0JQZmZ0bWxSNWs1SldzbURqVzREekJtSlVESGNGTGJHeXdoX2RiYktVM01BdTN3V04wdW9UbFRCQ1otXzMzS1dBSGjSAZgBQVVfeXFMTVJNTVdMYzF2NExyMmJ1SlFLVEh0MnN4Y1piQ3ZDVXBSNUVJVmZyLUlqcjdlMXpMYVZmdk1RTXFSQ1ZlbnlaZUR1ZUxOTjlyX2c0YnBhd0ppRHBzTUtFTWxwbkpMcks1Nkd4T2xXeFhvQzhlMlZiakpMNjlsS2U4ck9pUW85UXVqbmg2MlBtdGhwU3V2MGd2aEs?oc=5","date":"2026-01-26","type":"regulatory","source":"NDTV Profit","summary":"Sun Pharma, Cipla Recall Products In US: FDA - NDTV Profit","headline":"Sun Pharma, Cipla Recall Products In US: FDA","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}